Comparison of immune reconstitution after unrelated and related T-cell- depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions

Blood

Volumn 93, Issue 2, 1999, Pages 467-480

  Small, T N ^a   Papadopoulos, E B ^a   Boulad, F ^a   Black, P ^a   Castro Malaspina, H ^a   Childs, B H ^a   Collins, N ^a   Gillio, A ^a   George, D ^a   Jakubowski, A ^a   Heller, G ^a   Fazzari, M ^a   Kernan, N ^a   MacKinnon, S ^a   Szabolcs, P ^a   Young, J W ^a   O'Reilly, R J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GANCICLOVIR; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADOPTIVE TRANSFER; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFECTION SENSITIVITY; INFECTIOUS MONONUCLEOSIS; LEUKEMIA; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; OPPORTUNISTIC INFECTION; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; WHOLE BODY RADIATION;

EID: 0033555440     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.2.467     Document Type: Article

References (46)

1. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullogh J, McGlave P, Perkins Ham Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993
2. Nademanee A, Schmidt GM, Parker P, Dagis AC, Stein A, Snyder D, O'Donnell, Smith EP, Stepan DE, Molina A, Wong KK Margolin K, Somlo G, Littrell B, Woo D, Sniecinski I, Niland JC, Forman SJ: The outcome of matched, unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood 86:1228, 1995
3. Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TF, Clift RA, Petersdorf EW: Bone marrow transplantation from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 338:962, 1998
4. Geller RB, Devine SM, O'Toole K, Persons L, Keller J, Mauer D, Holland HK, Dix SP, Piotti M, Redei I, Connaghan G, Heffner LT, Hillyer CD, Waller EK, Winton EF, Wingard JR: Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high dose cyclophosphamide and fractionated total body irradiation. Bone Marrow Transplant 20:219, 1997
5. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW, Appelbaum FR, Buckner CD, Mathews D, Storb R, Sullivan KM, Hansen: Unrelated donor marrow transplantation in children. Blood 86:3247, 1995
6. Chown, SR, Marks DI, Cornish JM, Pamphilon DH, Potter CG, Steward CG, Oakhill A: Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission. Br J Haematol 99:36, 1997
7. Hongeng S, Krance RA, Bowman LC, Svrvastava DK, Cunningham JM, Horwitz EM, Brenner MK, Heslop HE: Outcome of transplantation with matched sibling and unrelated donor bone marrow in children with leukaemia. Lancet 350:767, 1997
8. Oakhill A, Pamphilon DH, Potter MN, Steward CG, Goodman S, Green A, Goulden P, Goulden NJ, Hale G, Waldmann H, Cornish JM: Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukemia in second remission. Br J Haematol 94:574, 1996
9. Casper J, Camiita B, Truitt R, Baxter-Lowe LA, Bunin N, Lawton C, Murray K, Hunter J, Pietryga D, Garbrecht F, Keever-Taylor C, Drowbyski W, Horowitz M, Flomenberg N, Ash R: Unrelated bone marrow transplants for children with leukemia or myelodysplasia. Blood 85:2354, 1995
10. Davies SM, Shu XO, Blazar BR, Filipovich AH, Kersey JH, Krivit W, McCollough J, Miller WJ, Ramsay NKC, Segall M, Wagner JE, Weisdorf DJ, McGlave PB: Unrelated donor bone marrow transplantation: Influence of HLA-A and -B incompatibility on outcome. Blood 86:1636, 1995
11. Speiser DE, Tiercy J-M, Rufer N, Grundschober C, Gratwohl A, Chapuis B, Helg C, Loliger C-C, Siren M-K, Roosnek E, Jeannet M: High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation, Blood 87:4455, 1996
12. Petersdorf EW, Longton GM, Anasetti C, Martin PJ, Mickelson EM, Smith AG, Jansen JA: The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated bone marrow transplantation. Blood 86:1606, 1995
13. Davies SM, Wagner JE, Xiao-Ou S, Balzar BR, Emmanuel K, Orchard PJ, Kersey JH, Dusenbery KE, Weisdorf DJ, McGlave PB, Ramsay NC: Unrelated donor bone marrow transplantation for children with acute leukemia. J Clin Oncol 15:557, 1997
14. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D: Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients. Blood 86:3979, 1995
15. Marks DI, Cullis JO, Ward KN, Lacey S, Zydlo R, Hughes TP, Schwarer AP, Lutz E, Barrett AJ, Hows JM, Batchelor JR, Goldman JM: Allogeneic bone marrow transplantation for chronic myelogenous leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 119:207, 1993
16. Mattsson J, Ringden O, Aschan J, Barkolt L, Dalianis T, Hagglund H, Ljungman P, Lonnqvist B, Tollemar J, Winiarski J, Remberger M: A low incidence of grade II to IV GVHD, but high mortality from infection using HLA-A,-B, and -DR identical unrelated donors and immunosuppression with ATG, Cyclosporine, and methrotrexate. Transplant Proc 29:735, 1997
17. Snyder DS, Chao NJ, Amylon MD, Taguchi J, Long GD, Neigin RS, Nademanee AP, O'Donnell MR, Schmidt GM, Stein AS, Parker PM, Smith EP, Stepan DE, Molin A, Lipsett JA, Hoppe RT, Niland JC, Dagis AC, Wong RM, Forman SJ, Blume KG: Fractionated total body irradiation and high dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 82:2920, 1993
18. Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Bryant E, Deeg HJ, Doney KC, Fisher LD, Hansen JA, Martin P, McDonald GB, Sanders JE, Schoch G, Singer J, Storb R, Sullivan KM, Witherspoon RP, Appelbaum FR: Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 84:2036, 1994
19. Soifer RJ, Fairclough D, Robertson M, Alyea E, Anderson K, Freedman A, Bartlett-Pandite L, Fisher D, Schlossman RL, Stone R, Murray C, Freeman A, Marcus K, Mauch P, Nadler L, Ritz J: CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission. Blood 89:3039, 1997
20. Small TN, Avigan D, Dupont B, Smith K, Black P, Heller G, Polyak T, O'Reilly RJ: Immune reconstitution following T-cell depleted bone marrow transplantation: Effect of age and post-transplant graft rejection prophylaxis. Biol Blood Marrow Transplant 3:65, 1997
21. Madrigal JA, Arguello R, Scott I, Avakian H: Molecular histocompatibility typing in unrelated donor bone marrow transplantation. Blood Rev 11:105, 1997
22. Prasad VK, Kernan NA, Heller G, O'Reilly RJ, Yang SYY: DNA typing for HLA-A and -B identifies disparities between patients and unrelated donors matched by HLA-A and -B serology and DRB1. Blood 90:562a, 1997 (abstr, suppl 1)
23. O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L: Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts. Immunol Rev 157:195, 1997
24. Heslop HE, Rooney CM: Adoptive cellular immunotherapy for EBV lymphoproliferative disease. Immunol Rev 157:217, 1997
25. Walter EA, Greenberg PD, Gilbert MJ, Rinch RJ, Watanabe KS, Thomas ED, Riddell SR: Reconstitution of cellular immunity against CMV in recipients of allogeneic bone marrow by adoptive transfer of T-cell clones from the donor. N Engl J Med 334:601, 1995
26. Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Rosenfield NS, Lieberman PH, Collins, NH, Boulad F, Carabasi MH, Castro-Malaspina H, Childs BH, Gillio AP, Small TN, Young JW, Kurtz RM, Kernan NA, O'Reilly RJ: Infusions of donor leukocytes as treatment of Epstein-Barr virus associated lymphoproliferative disorders complicating allogeneic marrow transplantation. N Engl J Med 330:1185, 1994
27. Bonini C, Ferrari G, Verzeletti S, Servida P, Zappone E, Ruggieri L, Ponzoni M, Rossini S, Mavillo F, Traversari C, Bordignon C: HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft versus leukemia. Science 276:1719, 1997
28. Yang SY: A standardized method for detection of HLA-A and HLA-B alleles by one dimensional isoelectric focusing (IEF) gel electrophoresis, in Dupont B (ed): Immunobiology of HLA: Histocompatibility Testing 1987. New York, NY, Springer-Verlag, 1989, p 332
29. Cereb N, May P, Lee S, Kong Y, Yang SY: Locus-specific amplification of HLA class I genes from genomic DNA: Locus-specific sequences in the first and third introns of HLA-A, -B, and -C allelles. Tissue Antigens 45:1, 1995
30. Kernan NA, Bordignon C, Heller G, Cunningham I, Castro-Malaspina H, Shank B, Flomenberg N, Burns J, Yang SY, Black P, O'Reilly RJ: Graft failure following T-cell depleted HLA-identical marrow transplants for leukemia: Analysis of risk factors and results of secondary transplants. Blood 74:2227, 1989
31. Pepe MS, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data. Stat Med 12:737, 1993
32. Armitage P, Berry G: Statistical Methods in Medical Research. Boston, MA, Blackwell Scientific, 1994
33. Zeger SL, Liang KY: An overview of methods for the analysis of longitudinal data. Stat Med 11:1825, 1992
34. Gaynor JJ: The use of time dependent covariates in modelling data from an occupational cohort study. Appl Stat 36:340, 1987
35. Hessner MJ, Endean D, Casper JT, Horowitz MM, Keever-Taylor CA, Roth M, Flomenberg N, Drobyski WR: Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 86:3987, 1995
36. Kook H, Goldman F, Padley D, Giller R, Rumelhart S, Holida M, Lee N, Peters C, Comito M, Huling D, Trigg M: Reconstruction of the immune system after unrelated or partially mismatched T-cell-depleted bone marrow transplantation in children: Immunophenotypic analysis and factors affecting the speed of recovery. Blood 88:1089, 1997
37. Sprent J: T lymphocytes and the thymus, in Paul WE (ed): Fundamental Immunology (ed 3). New York, NY, Raven, 1993, p 75
38. Small TN: Immunologic reconstitution following stem cell transplantation. Curr Opin Hematol 3:461, 1996
39. Weinberg K, Annett G, Kashyap A, Lenarsky C, Forman SJ, Parkman R: The effect of thymic function on immunocompentence following bone marrow transplantation. Biol Blood Marrow Transplant 1:18, 1995
40. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM, Wexler LH, Gress RE: Age, thymopoesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143, 1995
41. Lucas K, Small TN, Heller G, Dupont B, O'Reilly RJ: The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrrow transplantation. Blood 87:2594, 1996
42. Kernan NA, Collins NH, Juliano L, Cartagena T, Dupont B, O'Reilly RJ: Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 68:770, 1986
43. MacKinnon S, Papadopoulos EB, Carabasi MH, Reich L, Collins NH, Boulad F, Castro-Malaspina H, Childs B, Gillio A, Kernan NA, Small T, Young J, O'Reilly RJ: Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myelogenous leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 86:1261, 1995
44. Papadopoulos EB, Young JW, Barnett L, Childs BH, Castro-Malaspina H, Jakubowski A, MacKinnon S, O'Reilly RJ: Combined use of T cell depleted bone marrow transplants (TCDBMT) with donor leukocyte infusions (DLI) for treatment of patients with chronic myelogenous leukemia (CML). Blood 92:322a, 1998 (abstr, suppl 1)
45. Johnson BD, Drobyski WR, Truitt RL: Delayed infusion of normal donor cells after MHC-matched bone marrow transplant provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant 11:329, 1993
46. Salzberger B, Bowden RA, Hackman RC, Davis C, Boeckh M: Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: Risk factors and outcome. Blood 90:2502, 1997